Preethi Sundaram, Chief Strategy Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 113,572 shares at $16.25 ($1.9M) on 2022-11-11, disclosed to the SEC on 2022-11-15.
Open-market sale of $1.9M CPRX by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.25 | 28,393 | $461K | 24.8% |
| 2 | $16.25 | 28,393 | $461K | 24.8% |
| 3 | $16.50 | 28,393 | $468K | 25.2% |
| 4 | $16.50 | 28,393 | $468K | 25.2% |
| Total | $16.37 avg | 113,572 | $1.9M | 100% |
| Filing → |